Angelalign TechnologyAGLFF -1.74%73 EV-to-FCF is 24.85 as of Jul. 08, 2026, which is 69% below its 10-year median of 81.07. GuruFocus rates AGLFF with a GF Score™ of 73/100 and a GF Value™ of $12.51 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 416 Medical Devices & Instruments companies, Angelalign Technology ranks worse than 51.92% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Angelalign Technology's Enterprise Value is $1,252.1 Mil.
Angelalign Technology's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $50.4 Mil. Therefore, Angelalign Technology's EV-to-FCF for today is 24.85.
The historical rank and industry rank for Angelalign Technology's EV-to-FCF or its related term are showing as below:
AGLFF'
s EV-to-FCF Range Over the Past 10 Years
Min: -101.93 Med: 81.07 Max: 327.74
Current: 25.04
During the past 8 years, the highest EV-to-FCF of Angelalign Technology was 327.74. The lowest was -101.93. And the median was 81.07.
AGLFF's EV-to-FCF is ranked worse than 51.92% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.515
vs AGLFF: 25.04
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Angelalign Technology's PE Ratio (TTM) for today is calculated as:
Angelalign Technology's share price for today is $8.77.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Angelalign Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.170.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Angelalign Technology's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Angelalign Technology EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Angelalign Technology's EV-to-FCF falls into.
Angelalign Technology's current Enterprise Value is $1,252.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Angelalign Technology's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $50.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Angelalign Technology (AGLFF) has a EV-to-FCF of 24.85 as of Jul. 08, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Angelalign Technology and its competitors. This is 69% below median its historical median of 81.07. According to the industry distribution chart, Angelalign Technology ranks #216 out of 416 companies in the Medical Devices & Instruments industry, placing it in the top 51.9%.
Is Angelalign Technology's EV-to-FCF too high?
Angelalign Technology's current EV-to-FCF of 24.85 is 69% below median its 10-year median of 81.07. The Medical Devices & Instruments industry median EV-to-FCF is 23.52. Angelalign Technology's value of 24.85 is 5.7% above this industry median. Based on the distribution chart, Angelalign Technology ranks #216 out of 416 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Angelalign Technology has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Angelalign Technology's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Angelalign Technology ranks #216 out of 416 companies for EV-to-FCF. This places Angelalign Technology in the lower half of its industry. The industry median EV-to-FCF is 23.52. Angelalign Technology's value of 24.85 is 5.7% above this benchmark. While the company's 10-year median is 81.07 vs. the industry median of 23.52, Angelalign Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.52, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Angelalign Technology's current EV-to-FCF of 24.85 is 5.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Angelalign Technology and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Angelalign Technology's current EV-to-FCF is 24.85, which is 69% below median its own 10-year median of 81.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angelalign Technology stock overvalued right now?
Based on GuruFocus' analysis, Angelalign Technology (AGLFF) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.51, compared to a current price of $8.77 — trading 29.9% below its estimated fair value. The current EV-to-FCF is 24.85, which is 69% below median its 10-year median of 81.07 and 5.7% above the Medical Devices & Instruments industry median of 23.52. Angelalign Technology's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Angelalign Technology (AGLFF), the current EV-to-FCF is 24.85 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Angelalign Technology (AGLFF) Overvalued in 2026?
Based on GuruFocus' analysis, Angelalign Technology stock appears to be undervalued.
The current stock price of $8.77 is trading 29.9% below its estimated GF Value™ of $12.51.
GuruFocus considers Angelalign Technology to be Significantly Undervalued.
Key valuation signals for AGLFF:
EV-to-FCF: 24.85 (69% below median its 10-year median of 81.07)
GF Value™: $12.51 vs. price of $8.77 (29.9% below fair value)
Industry Position: 5.7% above the Medical Devices & Instruments median (#216 of 416)
No single metric tells the full story. See the AGLFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions, including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontic solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review, and modify treatment plans.
73GF Score
Get the complete analysis for AGLFF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AGLFF has been successfully added to your 
